Roxithromycin
General information:
| Withdrawn ID: | DB00778 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | J01FA06 |
| Molecular Formula: | C41H76N2O15 |
| Molweight: | 837.047 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1987 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Roxithromycin as primary suspect: | 4 |
|---|
Reported final outcomes:
| Hospitalization (initial or prolonged): | 3 |
|---|---|
| Disability: | 2 |
| Congenital anomaly: | 2 |
| Death: | 1 |
| Life-Threatening condition: | 1 |
Reported side-effects:
| Side-effect | Case number |
|---|---|
| Talipes | 2 |
| Strabismus | 2 |
| Macrocephaly | 2 |
| Limb hypoplasia congenital | 2 |
| Developmental hip dysplasia | 2 |
| Cryptorchism | 2 |
| Congenital multiplex arthrogryposis | 2 |
| Malaise | 1 |
| Exposure during pregnancy | 1 |
| DRUG INTERACTION | 1 |
| CLOSTRIDIUM DIFFICILE COLITIS | 1 |
Toxicity information:
| Toxicity class: | 4 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 1230 mg/kg |
External links:
| ChEBML: | CHEMBL1214185 |
|---|---|
| DrugBank: | DB00778 |